PIMREG and triple-A syndrome: Although no other plasma cysteinyl cathepsins in AAA patients have been reported, increased CatS levels may associate with increased AAA lesion CatS expression [4], [10], [11] and may serve as an independent risk factor and biomarker for human AAA.